A proprietary MMLV mutant with superior robustness and reliability in RT reactions.
$130.20 - $1,612.80
Invitrogen™ SuperScript IV Reverse Transcriptase (RT) is a proprietary MMLV mutant with superior robustness and reliability in RT reactions.
SuperScript™ IV Reverse Transcriptase (RT) is significantly improved over SuperScript III in inhibitor resistance, processivity, and reaction speed, while retaining all the benefits of the previous enzyme, including increased thermostability, highly efficient full-length cDNA synthesis, and reduced RNase activity. SuperScript IV RT is designed to provide reliable, consistent, and fast cDNA synthesis in the presence of inhibitors found in a wide variety of samples that cause other currently available RTs to perform inefficiently.SuperScript IV RT is the top choice for all RT-PCR and qRT-PCR applications in the SuperScript product family. We recommend it especially when reproducibility and reliability is the primary concern and when inhibitors in the RNA sample may interfere with cDNA synthesis, leading to biases in gene expression studies.Features of SuperScript IV Reverse Transcriptase include: